Sort
15,842 grants matching “pancreatic cancer”
Cancer, venous thromboembolic disease and tissue factor-bearing microparticles
$425,000Bruce Furie · Beth Israel Deaconess Medical Center · R01 · FY2011 · HL
Cancer, venous thromboembolic disease and tissue factor-bearing microparticles
$425,000Bruce Furie · Beth Israel Deaconess Medical Center · R01 · FY2009 · HL
Gene Analysis Shared Resource
$424,885Eric D Wieben · Mayo Clinic Rochester · P30 · FY2015 · CA
Project 4 :Using TME genetics and immunobiology to drive combination immunotherapies
$424,856Elizabeth Marion Jaffee · Johns Hopkins University · P50 · FY2018 · CA
Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitors
$424,794Melissa L Fishel · Indiana University Indianapolis · R01 · FY2022 · CA
Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitors
$424,794Melissa L Fishel · Indiana University Indianapolis · R01 · FY2023 · CA
Radiotherapy as Immunotherapy of Tumors
$424,777Samuel Strober · Stanford University · R01 · FY2014 · CA
Reprogramming the pancreatic tumor microenvironment with immunotherapy
$424,612Lei Zheng · Johns Hopkins University · R01 · FY2016 · CA
Reprogramming the pancreatic tumor microenvironment with immunotherapy
$424,612Lei Zheng · Johns Hopkins University · R01 · FY2015 · CA
South-Eastern Center for Imaging Animal Models of Cancer
$424,532John C Gore · Vanderbilt University · U24 · FY2009 · CA
Mechanisms of PAK1 activation, signaling and tumor resistance
$424,266Channing J Der · Univ Of North Carolina Chapel Hill · R01 · FY2016 · CA
Damage Sensing and Growth Control in the Drosophila Gut
$424,260Bruce A Edgar · University Of Utah · R01 · FY2019 · GM
Damage Sensing and Growth Control in the Drosophila Gut
$424,260Bruce A Edgar · University Of Utah · R01 · FY2020 · GM
Leveraging deep learning for markerless motion management in radiation therapy
$424,249Lei Xing · Stanford University · R01 · FY2023 · CA
Leveraging deep learning for markerless motion management in radiation therapy
$424,249Lei Xing · Stanford University · R01 · FY2022 · CA
PQ6: Therapeutic approaches for autonomic and neuroendocrine dysfunction in cancer cachexia
$424,120Aaron Grossberg · Oregon Health & Science University · R01 · FY2023 · CA
PQ6: Therapeutic approaches for autonomic and neuroendocrine dysfunction in cancer cachexia
$424,120Daniel L Marks · Oregon Health & Science University · R01 · FY2022 · CA
Physical Activity, Energy Balance, and Cancer
$424,095Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
Studying the role of eIF4A in Pancreatic Cancer
$423,880Christine Iok In Chio · Columbia University Health Sciences · R01 · FY2024 · CA
Dissecting the influence of DNA damage response and homologous recombination deficiencies on tumor immunogenicity
$423,750Robert M Samstein · Icahn School Of Medicine At Mount Sinai · DP5 · FY2023 · OD
Dissecting the influence of DNA damage response and homologous recombination deficiencies on tumor immunogenicity
$423,750Robert M Samstein · Icahn School Of Medicine At Mount Sinai · DP5 · FY2019 · OD
Dissecting the influence of DNA damage response and homologous recombination deficiencies on tumor immunogenicity
$423,750Robert M Samstein · Icahn School Of Medicine At Mount Sinai · DP5 · FY2022 · OD
Dissecting the influence of DNA damage response and homologous recombination deficiencies on tumor immunogenicity
$423,750Robert M Samstein · Icahn School Of Medicine At Mount Sinai · DP5 · FY2020 · OD
Dissecting the influence of DNA damage response and homologous recombination deficiencies on tumor immunogenicity
$423,750Robert M Samstein · Icahn School Of Medicine At Mount Sinai · DP5 · FY2021 · OD
Directing the metabolic fate of CAR T cells
$423,662Carl H. June · University Of Pennsylvania · R01 · FY2022 · CA